We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

RBCC Forms Joint Venture with Cutting-Edge Drug Delivery Company TheraKine

News   Mar 21, 2013

 
RBCC Forms Joint Venture with Cutting-Edge Drug Delivery Company TheraKine
 
 
 

RELATED ARTICLES

Oral Delivery of Nanoparticles

News

Nanoparticles show great promise as diagnostic tools and drug delivery agents. But until now, most nanoparticles had to be injected into the bloodstream because they weren’t absorbed well orally. Now, researchers have modified nanoparticles to improve their uptake in the gastrointestinal tract.

READ MORE

Scrap the Scratching: New Way to Treat an Itch

News

Two receptors in the spinal cord and the right experimental drug: Researchers at the University of Zurich have discovered a new approach that suppresses itch.

READ MORE

Tdap Vaccination for Pregnant Women Does Not Increase Risk of Autism, Finds Study

News

A Kaiser Permanente study of more than 80,000 children born over a 4-year period showed that the prenatal Tdap vaccination (tetanus, diphtheria, acellular pertussis) was not associated with increased risk of autism spectrum disorder in children.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE